Advertisement
Research ArticleArticle
Open Access

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models

Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

CRV431 Decreases Liver Fibrosis and Tumor Development

Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
Journal of Pharmacology and Experimental Therapeutics November 1, 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement